Data as of Aug 20
| -0.76 / -2.33%|
The 3 analysts offering 12-month price forecasts for Bio-Reference Laboratories Inc have a median target of 33.00, with a high estimate of 38.00 and a low estimate of 32.00. The median estimate represents a +4.08% increase from the last price of 31.71.
The current consensus among 4 polled investment analysts is to Buy stock in Bio-Reference Laboratories Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.